Jefferies Group’s GeneDx Holdings Warrant WGSWW Stock Holding History

Jefferies Group’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-177,651	Closed	-$174K	–	1977
2021 Q4	$174K	Hold	177,651	–	–	﹤0.01%	1419
2021 Q3	$377K	Buy	177,651 +33,308	+23%	+$109K	﹤0.01%	1319
2021 Q2	$664K	Hold	144,343	–	–	﹤0.01%	1097
2021 Q1	$730K	Buy	144,343 +95,972	+198%	+$534K	0.01%	998
2020 Q4	$132K	Buy	+48,371	New	+$122K	﹤0.01%	1430

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Jefferies Group's WGSWW Position: Q1 2022 in Review

Jefferies Group sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 177,651 shares — an estimated $174K sold.

Jefferies Group first reported a position in WGSWW in Q4 2020 and held it in 5 quarters. The position peaked at $730K in Q1 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

Jefferies Group reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
Jefferies Group sold 177,651 GeneDx Holdings Warrant shares in Q1 2022, an estimated $174K.
Jefferies Group first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 5 quarters.
Jefferies Group's GeneDx Holdings Warrant position peaked at $730K in Q1 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.